Author:
Wang Honglin,Lu Fangfang,Ni Xiuxian,Luo Rijing,Chen Linxiang,Yuan Jing,Zhang Zhen,Lv Qiuying
Abstract
Abstract
Background
The long-term sequelae of Coronavirus disease 2019 (COVID-19) in children are unclear. We investigated COVID-19 symptoms in school-aged children to determine their impact on patients and their families.
Methods
This cross-sectional study, conducted on February 25–28, 2023, selected a representative kindergarten and 9-year school from Shenzhen, China. There were randomly two classes each for the 12 grades from kindergarten to junior high school. The school-aged children were aged 3–16 years. Literate parents completed an online questionnaire related to their children’s COVID-19 symptoms since December 1, 2022. Descriptive statistics were computed as necessary. Univariate and multivariable linear regression analyses were performed, and variables with a p-value < 0.05 were considered to have a significant association with the subjective feeling scores for COVID-19 infection.
Results
We included 936 school-aged children, with a COVID-19 infection rate of 68.5%. The prevalence of LC 28 (illness with symptoms lasting for 28 days) was 3.4%. During acute infection, the median number of the 641 children’s symptoms was 3.0 (IQR: 1.0–5.0) and the median score of subjective feelings was 15.0 (IQR: 11.0–24.5). The top three symptoms were fever, cough/expectoration, and rhinobyon. Age of 13–16 years (adjusted beta: 3.60, 95% CI: 0.32–6.88) and comorbidities (adjusted beta: 3.47, 95% CI: 1.20–5.73) were independently associated with higher subjective feelings (p < 0.05). The top three characteristics associated with LC 28 were alopecia (33.3%, 5/15), cognitive dysfunction (29.2%, 7/24), and emotional problem (28.6%, 6/21).
Conclusions
Children with COVID-19 have a short duration of symptoms and milder symptoms, so they can self-medicate to minimize hospital crowding. Children with basic diseases require prompt attention. Although LC 28 is uncommon in children, mental and psychological problems after COVID-19 recovery should not be ignored.
Funder
The Key Project of Shenzhen Science and Technology Innovation Commission
Shenzhen Key Medical Discipline Construction Fund
Shenzhen San-Ming Project of Medicine in Shenzhen
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference28 articles.
1. World Health Organization. Listings of WHO’s response to COVID-19. Available at: Accessed on: 11 February 2022.
2. World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Available at: https://covid19.who.int/ Accessed on: March 13, 2023.
3. Asakawa T. Focusing on development of novel sampling approaches and alternative therapies for COVID-19: are they still useful in an era after the pandemic? Biosci Trends. 2022;16(6):386–8.
4. Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601–15.
5. COVID-19 rapid. Guideline: managing the long-term effects of COVID-19 (NG188. Evidence reviews 2 and 3: prevalence. London: National Institute for Health and Care Excellence (NICE); 2020.